Austin Bigley

Company: Indapta

Job title: Vice President of Research & Development

Seminars:

Utilizing the Superior Antibody-Dependent Cellular Cytotoxicity, Effector Functions, & Improved Persistence of g-NK Cells When Compared to Conventional NK Cells 3:30 pm

Discussing the enhanced in vivo efficacy and persistence of g-NK cells and the ability of g-NK cells to induce regression of established tumors leading to durable elimination of tumor burden Elucidating the unique feature of g-NK cells which enable the development of an off-the-shelf cancer immunotherapy combined with therapeutic IgG antibodies Combining g-NK cells with…Read more

day: Day 1 - Track B - Post Lunch